tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
CytomX Therapeutics Inc. (CTMX)
NASDAQ:CTMX
US Market
CTMX
CytomX Therapeutics
RESEARCH TOOLSreports

CytomX Therapeutics (CTMX) Stock News & Sentiment

Compare
933 Followers
CytomX Therapeutics Raises $234 Million in Equity Offering
Premium
Company Announcements
CytomX Therapeutics Raises $234 Million in Equity Offering
3d ago
8K
CTMX
CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures
Premium
Company Announcements
CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures
6d ago
CTMX
Varseta-M’s Differentiated Efficacy in Late-Line Colorectal Cancer Drives Higher Approval Odds and Upside to Target Price
Premium
Ratings
Varseta-M’s Differentiated Efficacy in Late-Line Colorectal Cancer Drives Higher Approval Odds and Upside to Target Price
6d ago
CTMX
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
Premium
TipRanks Newswire
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
6d ago
CTMX
NSRX
Options Volatility and Implied Earnings Moves Today, March 16, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 16, 2026
6d ago
NIU
AGEN
CytomX Therapeutics Inc. (CTMX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
CytomX Therapeutics Inc. (CTMX) Q4 Earnings Cheat Sheet
20d ago
CTMX
CytomX Therapeutics: Asymmetric Upside Ahead of Pivotal CX-2051 Colorectal Cancer Data Supports Reiterated Buy and $10 Target
Premium
Ratings
CytomX Therapeutics: Asymmetric Upside Ahead of Pivotal CX-2051 Colorectal Cancer Data Supports Reiterated Buy and $10 Target
2M ago
CTMX
More CTMX News >

CTMX News on the Web

Top CytomX Executives Quietly Unload Shares in a Wave of Insider Selling
TipRanks News
Neutral
CytomX Therapeutics Raises $234 Million in Equity Offering
TipRanks News
Neutral
CytomX Therapeutics price target raised to $16 from $10 at Barclays
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), CytomX Therapeutics (CTMX) and Johnson & Johnson (JNJ)
TipRanks News
Bullish
CytomX Therapeutics price target raised to $16 from $8 at Jefferies
TipRanks News
Neutral
CytomX Therapeutics price target raised to $15 from $10 at Guggenheim
TipRanks News
Bullish
CytomX Therapeutics 45.9M share Secondary priced at $5.30
TipRanks News
Neutral
CytomX Therapeutics’ $250 Million Equity Offering Strengthens Pipeline for Next-Generation Cancer Treatments
Market Chameleon
Neutral

News Score - Last 7 Days

Positive
CTMX
Sector Average
Media Buzz
This Week38 articles
Weekly Average11.75 articles
News Sentiment
This Week77%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CTMX’s Media Buzz Sentiment?
38 articles about CTMX were published this week. In an average week, 11.75 articles are published.
    What is CTMX’s weekly average amount of articles?
    In an average week, 11.75 articles about CTMX are published.
      What is CTMX’s News Sentiment?
      77% of articles about CTMX were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        ABOSAcumen Pharmaceuticals
        KMTSKestra Medical Technologies Ltd.
        MISTMilestone Pharmaceuticals
        OVIDOvid Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week